Abstract
Intraarterial fibrinolysis was performed in three patients with acute central retinal artery occlusion using recombinant tissue plasminogen activator as a fibrinolytic agent. In two cases the ophthalmic artery was selectively catheterized, and in the other a thrombolytic drug was infused into the ophthalmic artery by way of the meningeal collaterals. All patients experienced visual improvement. Fibrinolysis can produce better results than obtained from conservative treatment. A good prognosis can be achieved if the treatment starts within the first 4 to 5 hours after occlusion.
MeSH terms
-
Acute Disease
-
Aged
-
Anticoagulants / administration & dosage
-
Anticoagulants / therapeutic use
-
Blindness / therapy
-
Catheterization, Peripheral
-
Collateral Circulation / physiology
-
Fibrinolytic Agents / administration & dosage
-
Fibrinolytic Agents / therapeutic use*
-
Heparin / administration & dosage
-
Heparin / therapeutic use
-
Heparin, Low-Molecular-Weight / administration & dosage
-
Heparin, Low-Molecular-Weight / therapeutic use
-
Humans
-
Injections, Intra-Arterial
-
Male
-
Meningeal Arteries
-
Middle Aged
-
Ophthalmic Artery
-
Prognosis
-
Retinal Artery Occlusion / drug therapy*
-
Thrombolytic Therapy / methods*
-
Time Factors
-
Tissue Plasminogen Activator / administration & dosage
-
Tissue Plasminogen Activator / therapeutic use*
Substances
-
Anticoagulants
-
Fibrinolytic Agents
-
Heparin, Low-Molecular-Weight
-
Heparin
-
Tissue Plasminogen Activator